AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Update provided on program evaluating Proleukin interleukin-2.

Women's Health Weekly

| February 05, 2004 | COPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2004 FEB 5 - (NewsRx.com & NewsRx.net) -- Chiron Corporation (CHIR) announced that the company has decided to expand its program to evaluate the efficacy of Proleukin interleukin-2 (IL-2, aldesleukin) and rituximab in patients with low-grade non-Hodgkin lymphoma.

As part of the expansion of the program, Chiron will increase enrollment in its current phase II study in order to complete the trial. To date, the study has evaluated 29 patients. The company expects to complete enrollment in 2004.

"We have some provocative preliminary data in a patient population that has traditionally been refractory to the standard-of-care treatment. Therefore, we have decided to continue enrollment to better understand and quantify this signal," said Stephen Dilly, senior vice president and head of BioPharmaceuticals Development, Chiron BioPharmaceuticals. "The use of translational medicine techniques in this trial will be instrumental in identifying the sub-population that could benefit preferentially from IL-2 and mAb treatment. The expansion of our IL-2 program underscores Chiron's commitment to aggressively pursuing promising early data."

Chiron will also embark on a new ...

Related articles from newspapers, magazines, journals, and more
Charter Hospital Closings May Signal Bigger Problems Ahead, Reports Mental...
Press release article from: PR Newswire February 14, 2000 700+ words
...reports this week's issue of Mental Health Weekly. The stark numbers include 33 hospital...Karen Keiser-Jenkins told Mental Health Weekly last week. Keiser-Jenkins says the...Newswire. For more information on Mental Health Weekly, click on "Newsletters" to receive...
Problems With Managed Mental Health Program Hold Lesson For Other States,...
Press release article from: PR Newswire February 15, 1999 700+ words
...contract in state history, this week's issue of Mental Health Weekly reports. Earlier this month, the Montana legislature...Magellan. Center executive director Paul Meyer told Mental Health Weekly that in the last six months, Magellan has denied $500...
News You Can Use.(Rachel's Environmental and Health Weekly, periodical)(Brief...
Magazine article from: E Franz, Damon January 1, 2000 700+ words
...weekly publication of the Environmental Research Foundation (ERF). Much like its namesake, Rachel's Environment and Health Weekly sounds the warning about hazardous substances and technologies that threaten human and that environmental health. Rachel...
Children's treatment providers seek to bring down barriers. (includes related...
Newspaper article from: The Brown University Child and Adolescent Behavior Letter May 1, 1996 700+ words
...senior vice president of residential services at Las Vegas, NV-based Community Psychiatric Centers. Reprinted from Mental Health Weekly, Apr. 29, 1996, a sister publication of The Brown University Child and Adolescent Behavior Letter. RELATED ARTICLE...
Kids' programs face the ax. (federal aid to child mental health programs may be...
Newspaper article from: The Brown University Child and Adolescent Behavior Letter July 1, 1995 700+ words
...Bazelon Center for Mental Health Law. If we can't help those kids, who are we going to help?" Reprinted from the May 1 issue of Mental Health Weekly, sister publication of The Brown University Child and Adolescent Behavior Letter.
IL-21 induces tumor rejection by specific chemokines in syngeneic mice.
Magazine article from: Women's Health Weekly March 18, 2004 700+ words
...detected in mice rejecting TS/A-IL-21 cells. These data suggest that IL-21 represents a suitable adjuvant...the Journal of Immunology (IL-21 induces tumor rejection...article was prepared by Women's Health Weekly editors from staff and other...
IL-4 upregulated in AD patients treated with acetylcholinesterase inhibitors.
Newspaper article from: Mental Health Weekly Digest June 14, 2004 700+ words
...treated, have higher levels of IL-4 independently from age...The increased production of IL-4 in AChEI treated patients...in Experimental Gerontology (IL-4 in vitro production is upregulated...article was prepared by Mental Health Weekly Digest editors from staff and...
IL-6-174G/C genotype associated with BMD response to postmenopausal ERT.
Magazine article from: Women's Health Weekly August 5, 2004 700+ words
...variant is associated with lower IL-6 expression. As such, we...demonstrate the importance of IL-6 genotype in determining...Journal of Applied Physiology (IL-6-174G/C genotype is associated...article was prepared by Women's Health Weekly editors from staff and other...
JAK2-STAT5 signaling needed for microglia activation by IL-3.
Newspaper article from: Mental Health Weekly Digest March 22, 2004 700+ words
...pathway resulted in a decrease in IL-3-induced proliferation...a critical role in mediating IL-3-induced activation of...STAT5 pathway is essential for IL-3-Induced activation of...article was prepared by Mental Health Weekly Digest editors from staff and...
Antidepressants stimulate production of IL-6.
Newspaper article from: Mental Health Weekly Digest May 24, 2004 700+ words
...concluded the scientists. "IL-6 production was significantly...on the cytokine network and IL-6 production." Kubera and...antidepressants on the production of IL-6. Int Immunopharmacol...article was prepared by Mental Health Weekly Digest editors from staff and...
For more facts and information, see all results

Source: HighBeam Research, Update provided on program evaluating Proleukin interleukin-2.

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA